Skip to main content

4 Result(s)

within S Rosthøj Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

    PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) ...

    S. Modvig, H. Hallböök, H. O. Madsen, S. Siitonen, S. Rosthøj, A. Tierens… in Leukemia (2021)

    Download PDF (3601 KB) View Article

  2. Article

    Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen… in Leukemia (2020)

    Download PDF (603 KB) View Article

  3. No Access

    Article

    Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

    Minimal residual disease (MRD) measured by PCR of clonal IgH/TCR rearrangements predicts relapse in T-cell acute lymphoblastic leukemia (T-ALL) and serves as risk stratification tool. Since 10% of patients hav...

    S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen… in Leukemia (2019)

  4. No Access

    Article

    Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia

    Children with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) have an inferior prognosis compared with non-DS ALL patients. We reviewed methotrexate (MTX)/mercaptopurine (6MP) maintenance therapy dat...

    C Bohnstedt, M Levinsen, S Rosthøj, B Zeller, M Taskinen, S Hafsteinsdottir… in Leukemia (2013)